Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Medical Nutrition Products market in this environment.
In terms of revenue, this research report indicated that the global Medical Nutrition Products market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Medical Nutrition Products industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Abbott Nutrition Manufacturing aims at producing XX K Units Medical Nutrition Products in 2020, with XX % production to take place in global market, Arla Foods accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Medical Nutrition Products Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Medical Nutrition Products Market
Abbott Nutrition Manufacturing
Arla Foods
B. Braun Melsungen AG
Baxter International
DEMO
Fresenius Kabi AG
Hormel Health Labs
Hospira Inc
Koninklijke Frieslandcampina
Mead Johnson Nutrition Company
Nestl
Nutricia Advanced Medical Nutrition
Otsuka Pharmaceutical
Perrigo Nutritionals
Sichuan Kelun Pharmaceutical
Victus
Vitaflo International
...
Major Type of Medical Nutrition Products Covered in Prudent Markets report:
Enteral Medical Nutrition Products
Parenteral Medical Nutrition Products
Infant Medical Nutrition Products
Application Segments Covered in Prudent Markets Market
Healthy People
Sub-healthy People
Patient
Baby
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Medical Nutrition Products Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Enteral Medical Nutrition Products -Product Introduction and Major Manufacturers
1.1.2 Parenteral Medical Nutrition Products -Product Introduction and Major Manufacturers
1.1.3 Infant Medical Nutrition Products -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Medical Nutrition Products Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Medical Nutrition Products Market
3.1.1 Top Companies leading Medical Nutrition Products Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Medical Nutrition Products Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Medical Nutrition Products Market
3.2.1 Top Companies leading Medical Nutrition Products Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Medical Nutrition Products Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Medical Nutrition Products Market
3.3.1 Top Companies leading Medical Nutrition Products Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Medical Nutrition Products Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Medical Nutrition Products Market
3.4.1 Top Companies leading Medical Nutrition Products Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Medical Nutrition Products Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Medical Nutrition Products Market
3.5.1 Top Companies leading Medical Nutrition Products Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Medical Nutrition Products Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Medical Nutrition Products Market
3.6.1 Top Companies leading Medical Nutrition Products Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Medical Nutrition Products Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Medical Nutrition Products Market
3.7.1 Top Companies leading Medical Nutrition Products Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Medical Nutrition Products Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Medical Nutrition Products Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Medical Nutrition Products Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Medical Nutrition Products Sales and Growth Rate (2021-2027)
5.2 Global Medical Nutrition Products Sales Value and Growth Rate (2021-2027)
6 Medical Nutrition Products Competitive Analysis
6.1 Abbott Nutrition Manufacturing
6.1.1 Abbott Nutrition Manufacturing Company Profiles
6.1.2 Abbott Nutrition Manufacturing Product Introduction
6.1.3 Abbott Nutrition Manufacturing Medical Nutrition Products Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Arla Foods
6.2.1 Arla Foods Company Profiles
6.2.2 Arla Foods Product Introduction
6.2.3 Arla Foods Medical Nutrition Products Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 B. Braun Melsungen AG
6.3.1 B. Braun Melsungen AG Company Profiles
6.3.2 B. Braun Melsungen AG Product Introduction
6.3.3 B. Braun Melsungen AG Medical Nutrition Products Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Baxter International
6.4.1 Baxter International Company Profiles
6.4.2 Baxter International Product Introduction
6.4.3 Baxter International Medical Nutrition Products Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 DEMO
6.5.1 DEMO Company Profiles
6.5.2 DEMO Product Introduction
6.5.3 DEMO Medical Nutrition Products Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Fresenius Kabi AG
6.6.1 Fresenius Kabi AG Company Profiles
6.6.2 Fresenius Kabi AG Product Introduction
6.6.3 Fresenius Kabi AG Medical Nutrition Products Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Hormel Health Labs
6.7.1 Hormel Health Labs Company Profiles
6.7.2 Hormel Health Labs Product Introduction
6.7.3 Hormel Health Labs Medical Nutrition Products Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Hospira Inc
6.8.1 Hospira Inc Company Profiles
6.8.2 Hospira Inc Product Introduction
6.8.3 Hospira Inc Medical Nutrition Products Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Koninklijke Frieslandcampina
6.9.1 Koninklijke Frieslandcampina Company Profiles
6.9.2 Koninklijke Frieslandcampina Product Introduction
6.9.3 Koninklijke Frieslandcampina Medical Nutrition Products Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Mead Johnson Nutrition Company
6.10.1 Mead Johnson Nutrition Company Company Profiles
6.10.2 Mead Johnson Nutrition Company Product Introduction
6.10.3 Mead Johnson Nutrition Company Medical Nutrition Products Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Nestl
6.12 Nutricia Advanced Medical Nutrition
6.13 Otsuka Pharmaceutical
6.14 Perrigo Nutritionals
6.15 Sichuan Kelun Pharmaceutical
6.16 Victus
6.17 Vitaflo International
7 Conclusion